MarketBeat on MSN

Aclaris Therapeutics maps busy pipeline calendar, plans phase 2 asthma trial for ATI-052

Key Points Interested in Aclaris Therapeutics, Inc.? Here are five stocks we like better. Aclaris Therapeutics is preparing a ...
Zacks.com on MSN

Sanofi Stock Falls 6% in 3 Months: Should You Buy, Sell or Hold?

Sanofi’s SNY stock has declined 5.9% in the past three months despite reporting double-digit sales and earnings growth in the ...
Medscape

Asthma Control: How Much ICS Is Enough?

Low-dose ICS remain essential for every asthma patient, and GINA/CFA guidance favors phenotype-tailored step-up strategies ...
Truthout

3 of RFK Jr.’s Favorite Anti-Vax Studies Are Being Retracted or Scrutinized

Kennedy has responded to outbreaks of measles and whooping cough in the US by pushing disinformation about vaccines.